BSE filing, BSE: 544219. Summary written from the filing by ALFA Finder's alert engine.
VVIP Infratech Ltd: key numbers
- Share price
- ₹155.00
- Market cap
- ₹387.0 Cr
- Revenue (annual)
- ₹346.5 Cr
- Net profit (annual)
- ₹30.07 Cr
- P/E (TTM)
- 12.9×Sector 31.7×
- Promoter holding
- 68.61%
- FII holding
- 0.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from VVIP Infratech Ltd
All →VVIP Infratech Annual General Meeting
VVIP Infratech set 11 November 2026 as the cut-off date for its EGM on 18 November 2026. Remote e-voting runs from 15 to 17 November.
VVIP Infratech Convertible Warrants
VVIP Infratech's EGM on 18 November 2026 seeks approval for a ₹98.70 Cr preferential warrant issue. Warrants priced at ₹137 each go to promoter and non-promoter allottees.
- Value
- ₹98.70 Cr
VVIP Infratech Preferential Issue
VVIP Infratech appointed CS Sagar Saxena as scrutinizer for remote e-voting at its upcoming EGM. The EGM is to approve a preferential issue of equity shares.
VVIP Infratech Fund Raise of ₹128.7 Cr
VVIP Infratech's board approved a preferential issue of 72.04 lakh warrants at ₹137 each, raising ₹98.70 Crore, plus a ₹30 Crore investment in its subsidiary, VVIP Realtech.
- Value
- ₹128.7 Cr
VVIP Infratech Board Meeting Date
VVIP Infratech will hold a board meeting on October 22, 2026, to consider raising funds through a preferential issue of equity shares.
VVIP Infratech Management Change
VVIP Infratech shareholders approved the re-appointment of Vibhor Tyagi as Whole-Time Director and the appointment of Adarsh Rastogi as Independent Director. Both decisions were finalized at the 25th AGM.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.